Literature DB >> 12781327

Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?

Gang Wei1, Jonathan Moss, Chun Su Yuan.   

Abstract

Opioid compounds are commonly used pain medications. However, their administration is associated with a number of side-effects. Among them, opioid-induced immunosuppression is a significant medical problem, which is evidenced by a strong association between the use of opioids and exacerbated infections, including AIDS. Research data have demonstrated the effects of opioids to be suppressive on phagocytic, natural killer (NK), B and T cells. However, these immunosuppressive effects may be mediated by mechanisms different from those for antinociceptive actions. This article reviews possible central and peripheral mechanisms of opioid-induced immunosuppression. To the extent that peripherally mediated immunosuppressive effects play a significant role in opioid-induced immunosuppression, novel peripheral opioid antagonists may have a therapeutic role in attenuating opioid-induced immunosuppression without affecting analgesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781327     DOI: 10.1016/s0006-2952(03)00085-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

Review 1.  Morphine: double-faced roles in the regulation of tumor development.

Authors:  X Y Zhang; Y X Liang; Y Yan; Z Dai; H C Chu
Journal:  Clin Transl Oncol       Date:  2017-11-10       Impact factor: 3.405

2.  Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.

Authors:  Kathryn L Hamilton; La 'Tonyia M Franklin; Sabita Roy; Lisa M Schrott
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

3.  Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats.

Authors:  Nahid Fakhraei; Nina Javadian; Reza Rahimian; Fatemeh Nili; Nastaran Rahimi; Shiva Hashemizadeh; Ahmad Reza Dehpour
Journal:  Inflammopharmacology       Date:  2018-10-15       Impact factor: 4.473

4.  Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling.

Authors:  Jason R Goldsmith; Joshua M Uronis; Christian Jobin
Journal:  Am J Pathol       Date:  2011-06-13       Impact factor: 4.307

5.  Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial.

Authors:  Pin Wu; Lu Zhu; Shi-Yu Zheng; Jun-Xiong Li; Meng-Die Wu; Wen-Jia Wang; Yu-Chao Hou; Jing Li; Huan-Gan Wu
Journal:  J Pain Res       Date:  2022-07-06       Impact factor: 2.832

Review 6.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  Effects of remifentanyl and fentanyl on LPS-induced cytokine release in human whole blood in vitro.

Authors:  Yun Wu; Yanlin Wang; Jia Zhan
Journal:  Mol Biol Rep       Date:  2008-06-25       Impact factor: 2.316

8.  Dr William Coley and tumour regression: a place in history or in the future.

Authors:  S A Hoption Cann; J P van Netten; C van Netten
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

9.  Inflammasome in drug abuse.

Authors:  Enquan Xu; Jianuo Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

10.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.